Loading provider…
Loading provider…
Dermatology Physician in Dania, FL
NPI: 1053308965Primary Practice Location
MEMORIAL REGIONAL HOSPITAL
1005 Joe Dimaggio Dr, Hollywood, FL
Primary Employer
Dermatology Group of Florida, P.A.
dermgroup.net
HQ Phone
Get MD Eduardo's Phone Numberphone_androidMobile
Get MD Eduardo's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1998 - 2026
NY State Medical License
2013 - 2026

American Board of Dermatology
Dermatology

American Board of Dermatology
Micrographic Dermatologic Surgery
University of Miami/Jackson Health System
Residency • Dermatology
1996 - 1999
Internship • Transitional Year
1995 - 1996
Central University of Venezuela
Medical School
Until 1982
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 229 | 390 |
| 2 | 17311Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | 212 | 243 |
| 3 | 17000Destruction of skin growth | 131 | 172 |
| 4 | 17003Destruction of 2-14 skin growths | 110 | 659 |
| 5 | 17312Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | 91 | 131 |
Authors: Eli Saleeby, Carolina Puyana
Journal: J Drugs Dermatol
ASDS Cosmetic Dermatologic Surgery Fellowship Milestones.
Authors: Jeffrey Dover, Roy Geronemus, Daniel Friedmann, Kenneth Arndt, Jeremy Green, Sabrina Fabi, Mitchel Goldman, Omar Ibrahimi, Susan Weinkle, Arisa Ortiz
Journal: Dermatol Surg
Lead Sponsor: Avita Medical
Intervention / Treatment: DEVICE: Control Intervention (UVB), DEVICE: Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB)
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: LY3041658